var _paq = window._paq = window._paq || []; /* tracker methods like "setCustomDimension" should be called before "trackPageView" */ _paq.push(['trackPageView']); _paq.push(['enableLinkTracking']); (function() { var u="https://rwrregs.matomo.cloud/"; _paq.push(['setTrackerUrl', u+'matomo.php']); _paq.push(['setSiteId', '1']); var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0]; g.async=true; g.data-privacy-src='//cdn.matomo.cloud/rwrregs.matomo.cloud/matomo.js'; s.parentNode.insertBefore(g,s); })();

USA | RAISE Action Framework to Improve Race and Ethnicity Data Collection in Health Care

Please login to view this page.

USA | RAISE Action Framework to Improve Race and Ethnicity Data Collection in Health Care2024-09-01T11:32:40+00:00

USA | New Draft FDA Guidance: Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products

Please login to view this page.

USA | New Draft FDA Guidance: Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products2024-02-08T13:27:50+00:00

USA | Draft FDA Guidance – Postmarketing Approaches to Obtain Data on Populations Underrepresented in Clinical Trials for Drugs and Biological Products

Please login to view this page.

USA | Draft FDA Guidance – Postmarketing Approaches to Obtain Data on Populations Underrepresented in Clinical Trials for Drugs and Biological Products2023-09-05T11:18:16+00:00

USA | FDA Takes Important Steps to Increase Racial and Ethnic Diversity in Clinical Trials

Please login to view this page.

USA | FDA Takes Important Steps to Increase Racial and Ethnic Diversity in Clinical Trials2022-08-07T16:35:01+00:00
Go to Top